FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileAFT Pharmaceuticals Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Discussion
AFP.AX
AFT Pharmaceuticals Limited Stock AnalysisComprehensive stock analysis for AFT Pharmaceuticals Limited (AFP.AX) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisAFP.AX
AFP.AX
AFT Pharmaceuticals Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Discussion
AFP.AX
  1. Home
  2. Stocks
  3. AFT Pharmaceuticals Limited

AFT Pharmaceuticals Limited

🇦🇺AFP.AX•ASX

AFT Pharmaceuticals Limited

🇦🇺AFP.AX•ASX
P/E ratio
32.46

Your view on AFP.AX

P/E
32.46
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About AFT Pharmaceuticals Limited

Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Hartley Atkinson
Headquarters
129 Hurstmere Road, Auckland, AUK, NZ
Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Hartley Atkinson
Headquarters
129 Hurstmere Road, Auckland, AUK, NZ
Description

AFT Pharmaceuticals Limited engages in the complete lifecycle of pharmaceutical products, from their initial development and licensing to their distribution and ultimate sale. The company's reach extends throughout New Zealand, Australia, Asia, and various other international markets.

Its extensive product range encompasses treatments for allergies, cold and flu symptoms, ophthalmic conditions, first aid, pain management, digestive health, dermatological concerns, and medicated vitamin supplements. Established in 1997, AFT Pharmaceuticals has its corporate headquarters situated in Auckland, New Zealand.

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for AFT Pharmaceuticals Limited. Starting points for AFT Pharmaceuticals Limited: P/E 32.5, EPS AUD 0.14, beta 0.42 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for AFT Pharmaceuticals Limited. AFT Pharmaceuticals Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for AFT Pharmaceuticals Limited. Trailing twelve-month EPS for AFT Pharmaceuticals Limited stands at AUD 0.14. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Wall Street analysts· not FRC research
Nov 22, 2026
More →

Earnings per share estimates

Per shareThis quarterSep 2026Next quarterMar 2027This yearYear to Mar 2027Next yearYear to Mar 2028
Average estimateNZD 0.00NZD 0.00NZD 0.19NZD 0.24
Lowest estimateNZD 0.00NZD 0.00NZD 0.19NZD 0.23
Highest estimateNZD 0.00NZD 0.00NZD 0.19NZD 0.24
Number of analysts0011
A year agoNZD 0.061NZD 0.081NZD 0.15—
Growth vs a year ago——+24.9%—

1The year-ago figure includes one-time items, so growth is not shown.

Revenue estimates

TotalThis quarterSep 2026Next quarterMar 2027This yearYear to Mar 2027Next yearYear to Mar 2028
Average estimateNZD 138.03MNZD 170.41MNZD 309.67MNZD 351.87M
Lowest estimateNZD 138.03MNZD 170.41MNZD 308.82MNZD 349.24M
Highest estimateNZD 138.03MNZD 170.41MNZD 310.53MNZD 354.49M
Number of analysts1122
A year agoNZD 64.28MNZD 90.89MNZD 256.56M—
Growth vs a year ago+114.7%+87.5%+20.7%—

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for AFT Pharmaceuticals Limited. AFT Pharmaceuticals Limited has reported as a listed company since 2016. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold AFP.AX20 companies
Compare AFP.AX with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis
Peer companies
TickerTypeCompanySectorIndustry
ARX.AXAroa Biosurgery LimitedHealthcareMedical - Devices—
AVR.AXAnteris Technologies LtdHealthcareMedical - Devices—
BOT.AXBotanix Pharmaceuticals LimitedHealthcareBiotechnology—
DXB.AXDimerix LimitedHealthcareBiotechnology—
IMR.AXImricor Medical Systems, Inc.HealthcareMedical - Specialties—
MVF.AXMonash IVF Group LimitedHealthcareMedical - Diagnostics & Research—
MYX.AXMayne Pharma Group LimitedHealthcareMedical - Pharmaceuticals—
OCC.AXOrthocell LimitedHealthcareBiotechnology—
More Drug Manufacturers - Specialty & Generic companies
TickerTypeCompanySectorExchangeMkt cap
TRUFFRed Light Holland Corp.HealthcareOTC$5.5M
TSMRFTsumura & Co.HealthcareOTC$1.7B
PAHCPhibro Animal Health CorporationHealthcareNASDAQ$1.4B
PAIOFPaion AGHealthcareOTC$75,264
PBF.CNPlanet Based Foods Global Inc.HealthcareCNQ$1.4M
PBFFFPlanet Based Foods Global Inc.HealthcareOTC$825,651
PCLO.VPharmaCielo Ltd.HealthcareTSXV—
PCLOFPharmaCielo Ltd.HealthcareOTC$7.1M
PCRXPacira BioSciences, Inc.HealthcareNASDAQ$1.5B
PCYNProcyon CorporationHealthcareOTC$1.5M
PEMTFThoughtful Brands Inc.HealthcareOTC$368
PER.AXPercheron Therapeutics LimitedHealthcareASX—
Open Comparable Analysis
Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of AFT Pharmaceuticals Limited.

AFP.AX AnalysisGood
Past
4
Growth
5
Health
3
Profit
3
Value
1